Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors

British Journal of Cancer

Volumn 82, Issue 12, 2000, Pages 1958-1966

  Simony Lafontaine, J ^a   Esslimani, M ^a   Bribes, E ^b   Gourgou, S ^a   Lequeux, N ^a   Lavail, R ^a   Grenier, J ^a   Kramar, A ^a   Casellas, P ^b  

^a CENTRE VAL D AURELLE   (France)

^b SANOFI   (France)

Author keywords

Breast cancer; Human sterol isomerase; Immunocytochemistry; Prognostic factors; Sigma 1 receptor; SR BP 1

Indexed keywords

HORMONE RECEPTOR; ISOMERASE; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; SIGMA 1 OPIATE RECEPTOR; STEROID RECEPTOR; STEROL;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENOPAUSE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARRIER PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MENOPAUSE; MIDDLE AGED; PROGNOSIS; RECEPTORS, SIGMA; STEROID ISOMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0034071092     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bloom HJG and Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377
2. Bukholm IK, Nesland JM, Karesen R, Jacobsen U and Borresen-Dale A-L (1907) Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53. Int J Cancer 73: 38-41
3. Casellas P, Bourrie B, Canat X, Carayon P, Buisson I, Paul R, Breliere JC and Le Fur G (1994) Immunopharmacological profile of SR31747: in vitro and in vivo studies on humoral and cellular responses. J Neuroimmunol 52: 193-203
4. Chan WK, Poulsom R, Lu QL, Patel K, Gregory W, Fisher CJ and Hanby AM (1993) Bcl-2 expression in invasive mammary carcinoma: correlation with apoptosis, hormone receptors and p53 expression. J Pathol 169: 138
5. Cullett K, Hartveit F, Skjaerven R and Maehle BO (1996) Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status. J Clin Pathol 49: 920-925
6. Derocq JM, Bourrie B, Segui M, Le Fur G and Casellas P (1995) In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747. J Pharmacol Exp Ther 272: 224-230
7. Dussossoy D, Carayon P, Belugou S, Feraut D, Bord A, Goubet C, Roque C, Vidal H, Combes T, Loison G and Casellas P (1999) Colocalization of sterol isomerase and sigma 1 receptor at endoplasmic reticulum and nuclear envelope level. Eur J Biochem 263: 377-386
8. Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
9. Elston CW (1987) The assessment of histological grade in breast cancer. Aust NZJ Surg 54: 11-15
10. Gee JMW, Robertson JFR, Ellis IO, Willsher P, Maclelland RA, Hoyle HB, Kyme SR, Finlay P, Blamey RW and Nicholson RI (1994) Immunocytochemical localization of Bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 59: 619-628
11. Hawkins RA, Tesdale AL, Killen ME, Jack WJL, Chetty U, Dixon JM, Hulme MJ, Prescott RJ, Mcintyre MA and Miller WR (1996) Prospective evaluation of prognostic factors in operable breast cancer. Br J Cancer 74: 1469-1478
12. Hellemans P, van Dam PA, Weyler J, van Oosterom AI, Buytaert P and Marck EV (1995) Prognostic value of Bcl-2 expression in invasive breast cancer. Br J Cancer 72: 354-360
13. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
14. Jbilo O, Vidal H, Paul R, De Nys N, Bensaid M, Silve S, Carayon P, Davi D, Galiegue S, Bourrie B, Guillemot JC, Ferrera P, Loison G, Maffrand JP, Le Fur G and Casellas P (1997) Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase. J Biol Chem 272: 27107-27115
15. Johnston SRD, MacLean KA, Sacks NPM, Salter J, Smith IE and Dowsett M (1994) Modulation of Bcl-2 and Ki-67 expression in estrogen receptor-positive human breast cancer by tamoxifen. Eur J Cancer 30A: 1663-1669
16. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-886
17. Labit-Le Bouteiller C, Jamme MF, David M, Silve S, Lanau C, Dhers C, Picard C, Rahier A, Taton M, Loison G, Caput D, Ferrara P and Lupker (1998) Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step. Eur J Biochem 256: 342-349
18. Leek RD, Kaklamanis L, Pezzella F, Gatter KC and Harris AL (1994) Bcl-2 in normal breast and carcinoma with estrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br J Cancer 69: 135-139
19. 7 sterol isomerase. J Pharmacol Exp They 285: 1296-1302
20. Seth P, Leibach FH and Ganapathy V (1997) Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun 241: 535-540
21. Mink D, Tngelen BV, Villena-Heinsen C, Heiss C and Schmidt W (1994) Breast cancer and prognostic factors. Tumor size, degree of differentiation, proliferation kinetics and expression of steroid hormone receptors. Eur J Gynaecol Oncol 6: 424-436
22. Pichon MF, Broet P, Magdelenat H, Delarue JC, Spyratos F, Basuyau JP, Saez S. Rallet A, Courriere P, Millon R and Asselain B (1996) Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer 73: 1545-1551
23. Robertson JF (1996) Oestrogen receptor a stable phenotype in breast cancer. Br J Cancer 73: 5-12
24. Silve S, Leplatois P, Josse A, Dupuy PH, Lanau C, Kaghad M, Dhers C, Picard C, Rahier A, Taton M, Le Fur G, Caput D, Ferrara P and Loison G (1996) The immunosuppressant SR 31747 blocks cell proliferation by inhibing a steroid isomerase in Saccharomyces cerevisiae. Mol Cell Biol 16: 2719-2727
25. Van Slooten HJ, van de Vijver MJ, van de Velde CJ and van Dierendonek JH (1998) Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer 77: 789-796
26. Su TP (1991) σ receptors: putative links between nervous, endocrine and immune systems. Eur J Biochem 200: 633-642